[Preprint] Open-label RCT: Baricitinib noninferior to Tocilizu | Critical Care & Emergencies

[Preprint] Open-label RCT: Baricitinib noninferior to Tocilizumab in hospitalized patients with severe COVID-19.

https://www.linksmedicus.com/news/preprint-open-label-rct-baricitinib-noninferior-tocilizumab-hospitalized-patients-severe-covid-19/